zinc oxide has been researched along with Experimental Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Qi, L; Qiu, F; Yang, N; Zhu, F | 1 |
| Byun, SW; Cho, NH; Jang, NY; Kim, Y; Kim, YJ; Kim, YK; Lee, JW; Park, BC; Sharma, P; Shin, JB | 1 |
| Ding, WP; Dong, L; Hu, Y; Lin, J; Qiu, BS; Wei, PF; Wen, LP; Xu, MR; Zhang, HR; Zhang, JQ; Zhang, L; Zhang, YJ | 1 |
| Al-Khedhairy, AA; Choi, EH; Dwivedi, S; Kaushik, N; Kaushik, NK; Musarrat, J; Umar, A; Wahab, R | 1 |
| Cao, HM; Kong, JL; Ma, YY; Möhwald, H; Xiong, HM; Ye, DX; Zhao, W | 1 |
| Baev, A; Damasco, JA; Gu, B; Kuzmin, AN; Ohulchanskyy, TY; Pliss, A; Prasad, PN; Wen, S; Yong, KT | 1 |
| Kong, J; Li, Y; Qingguang, R; Song, W; Sun, Y; Tang, X | 1 |
7 other study(ies) available for zinc oxide and Experimental Neoplasms
| Article | Year |
|---|---|
Therapeutic Potential of Zinc Oxide-Loaded Syringic Acid Against in vitro and in vivo Model of Lung Cancer.
Topics: A549 Cells; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Benzo(a)pyrene; Female; Gallic Acid; Humans; Lung Neoplasms; Male; Membrane Potential, Mitochondrial; Metal Nanoparticles; Mice; Neoplasms, Experimental; Reactive Oxygen Species; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction; Zinc Oxide | 2020 |
Application of radially grown ZnO nanowires on poly-l-lactide microfibers complexed with a tumor antigen for cancer immunotherapy.
Topics: Animals; Antigens, Neoplasm; Cell Line, Tumor; Dendritic Cells; Drug Carriers; Immunity, Cellular; Immunotherapy; Mice; Nanocomposites; Nanowires; Neoplasms, Experimental; Polyesters; T-Lymphocytes, Regulatory; Zinc Oxide | 2019 |
Enhancing tumor chemotherapy and overcoming drug resistance through autophagy-mediated intracellular dissolution of zinc oxide nanoparticles.
Topics: Animals; Antineoplastic Agents; Autophagic Cell Death; Doxorubicin; Drug Resistance, Neoplasm; Female; HeLa Cells; Humans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasms, Experimental; Reactive Oxygen Species; Zinc Oxide | 2019 |
ZnO nanoparticles induces cell death in malignant human T98G gliomas, KB and non-malignant HEK cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Humans; Nanoparticles; Neoplasms, Experimental; Treatment Outcome; Zinc Oxide | 2013 |
ZnO-Based Nanoplatforms for Labeling and Treatment of Mouse Tumors without Detectable Toxic Side Effects.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Contrast Media; Doxorubicin; Drug Carriers; Fluorescent Dyes; Gadolinium; Humans; Magnetic Resonance Imaging; Methacrylates; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Particle Size; Polyethylene Glycols; Quantum Dots; Surface Properties; Tissue Distribution; Zinc Oxide | 2016 |
In-situ second harmonic generation by cancer cell targeting ZnO nanocrystals to effect photodynamic action in subcellular space.
Topics: Chlorophyllides; Folic Acid; HeLa Cells; Humans; Infrared Rays; Nanocapsules; Neoplasms, Experimental; Photochemotherapy; Porphyrins; Second Harmonic Generation Microscopy; Treatment Outcome; Zinc Oxide | 2016 |
In situ detection of the Zn(2+) release process of ZnO NPs in tumour cells by confocal laser scanning fluorescence microscopy.
Topics: Diffusion; HeLa Cells; Humans; Intravital Microscopy; Metal Nanoparticles; Microscopy, Confocal; Microscopy, Fluorescence; Molecular Imaging; Neoplasms, Experimental; Reproducibility of Results; Sensitivity and Specificity; Zinc; Zinc Oxide | 2016 |